Bio-Rad Laboratories (BIO) EBT Growth (3y) (2012 - 2026)
Powered by 
Analysis
Bio-Rad Laboratories (BIO) EBT Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.48 Bn | 221.41 Bn | 8.34 Bn | 10.40% |
| 2 | Danaher | 144.42 Bn | 140.08 Bn | 3.61 Bn | -1.90% |
| 3 | Agilent Technologies | 40.86 Bn | 39.11 Bn | 1.04 Bn | 49.83% |
| 4 | Illumina | 30.97 Bn | 29.80 Bn | 770.00 Mn | 70.10% |
| 5 | Revvity | 13.85 Bn | 12.83 Bn | 416.87 Mn | -3.89% |
| 6 | Bio-Techne | 11.27 Bn | 11.01 Bn | 211.39 Mn | -7.16% |
| 7 | Bio-Rad Laboratories | 10.11 Bn | 8.49 Bn | 345.80 Mn | 33.16% |
| 8 | Repligen | 9.33 Bn | 8.31 Bn | 110.04 Mn | -17.17% |
| 9 | 10x Genomics | 8.77 Bn | 8.21 Bn | 112.50 Mn | 32.55% |
| 10 | Bruker | 8.30 Bn | 8.09 Bn | 416.00 Mn | -42.21% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33.16% |
| Mar 31, 2026 | -116.38% |
| Dec 31, 2025 | -5.22% |
| Sep 30, 2025 | -27.64% |
| Jun 30, 2025 | 32.75% |
| Mar 31, 2025 | 26.39% |
| Dec 31, 2024 | 23.46% |
| Sep 30, 2024 | -44.43% |
| Jun 30, 2024 | -63.97% |
| Mar 31, 2024 | -27.66% |
| Dec 31, 2023 | -26.73% |
| Sep 30, 2023 | -56.66% |
| Jun 30, 2023 | -47.43% |
| Mar 31, 2023 | -54.47% |
| Dec 31, 2022 | 15.99% |
| Sep 30, 2022 | 14.80% |
| Jun 30, 2022 | -53.06% |
| Mar 31, 2022 | -80.44% |
| Dec 31, 2021 | -24.87% |
| Sep 30, 2021 | 142.97% |